Epigallocatechin-3-Gallate Dampens Non-Alcoholic Fatty Liver by Modulating Liver Function, Lipid Profile and Macrophage Polarization

Epigallocatechin-3-Gallate Dampens Non-Alcoholic Fatty Liver by Modulating Liver Function, Lipid Profile and Macrophage Polarization

Epigallocatechin-3-gallate (EGCG) has been shown to attenuate obesity, fatty liver disease, hepatic inflammation and lipid profiles. Here, we validate the efficacy of EGCG in a murine model of non-alcoholic fatty liver disease (NAFLD) and extend the mechanistic insights. NAFLD was induced in mice by...

Full description

Bibliographic Details
Main Authors: Yong Du, Laura Paglicawan, Sanam Soomro, Omar Abunofal, Sahar Baig, Kamala Vanarsa, John Hicks, Chandra Mohan
Format: Article
Language:English
Published: MDPI AG 2021-02-01
Series:Nutrients
Subjects:
non-alcoholic fatty liver disease
epigallocatechin-3-gallate
inflammation
macrophage polarization
Online Access:https://www.mdpi.com/2072-6643/13/2/599

Internet

https://www.mdpi.com/2072-6643/13/2/599

Similar Items